Advanced search
Start date
Betweenand

Renato Ramos Massaro

CV Lattes


Universidade de São Paulo (USP). Faculdade de Ciências Farmacêuticas (FCF)  (Institutional affiliation for the last research proposal)
Birthplace: Brazil

bachelor's at Ciências Biológicas - Bacharelado from Universidade de São Paulo (2006), bachelor's at Ciências Biológicas - Licenciatura from Universidade de São Paulo (2007), master's at Pharmacy from Universidade de São Paulo (2009) and doctorate at Pharmacy from Universidade de São Paulo (2014). , acting on the following subjects: mmp, glioma, reck, melanoma, and 2-metoxiestradiol. (Source: Lattes Curriculum)

Scholarships abroad
FAPESP support in numbers * Updated October 17, 2020
Total / Available in English
3 / 0 Completed scholarships in Brazil
1 / 1 Completed scholarships abroad
4 / 1 All Scholarships

Associated processes
Contact researcher

Use this Research Supported by FAPESP (BV/FAPESP) channel only to send messages referring to FAPESP-funded scientific projects.


 

 

 

 

Keywords used by the researcher
Scientific publications resulting from Research Grants and Scholarships under the grantee's responsibility (2)

(References retrieved automatically from Web of Science and SciELO through information on FAPESP grants and their corresponding numbers as mentioned in the publications by the authors)

Publications2
Citations35
Cit./Article17.5
Data from Web of Science

MASSARO, R. R.; FAIAO-FLORES, F.; REBECCA, V. W.; SANDRI, S.; ALVES-FERNANDES, D. K.; PENNACCHI, P. C.; SMALLEY, K. S. M.; MARIA-ENGLER, S. S.. Inhibition of proliferation and invasion in 2D and 3D models by 2-methoxyestradiol in human melanoma cells. PHARMACOLOGICAL RESEARCH, v. 119, p. 242-250, . Web of Science Citations: 8. (14/24400-0, 12/05732-7, 13/05172-4, 15/10821-7)

REBECCA, VITO W.; MASSARO, RENATO R.; FEDORENKO, INNA V.; SONDAK, VERNON K.; ANDERSON, ALEXANDER R. A.; KIM, EUNJUNG; AMARAVADI, RAVI K.; MARIA-ENGLER, SILVYA S.; MESSINA, JANE L.; GIBNEY, GEOFFREY T.; et al. Inhibition of autophagy enhances the effects of the AKT inhibitor MK-2206 when combined with paclitaxel and carboplatin in BRAF wild-type melanoma. PIGMENT CELL & MELANOMA RESEARCH, v. 27, n. 3, p. 465-478, . Web of Science Citations: 27. (12/05732-7)

Please report errors in researcher information by writing to: cdi@fapesp.br.
X

Report errors in this page


Error details: